Back to D. E. Shaw & Co., Inc.

ABT
Showing 8 of 27 quarters

Position history for D. E. Shaw & Co., Inc.'s holdings in ABBOTT LABORATORIES

D. E. Shaw & Co., Inc. holds 5.3M shares of ABT (ABBOTT LABORATORIES), worth $542.1M as of 2026-Q1. The position was increased (+290.2% shares). ABT represents 0.3% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$542.1M

Current Shares

5.3M

Total Value Change

+$436.2M

Total Shares Change

+4.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.3M
+290.2%
$542.1M0.3%$113.61
61
2025-Q4
Increased
1.4M
+3296.4%
$169.5M0.1%$125.15
49
2025-Q3
Increased
39,842
+534.5%
$5.3M0.0%$131.85
44
2025-Q2
Decreased
6,279
-63.4%
$854,0070.0%$132.52
0
2025-Q1
Decreased
17,130
-41.0%
$2.3M0.0%$128.41
0
2024-Q4
Decreased
29,056
-69.9%
$3.3M0.0%$110.14
0
2024-Q3
Decreased
96,479
-90.5%
$11M0.0%$109.27
0
2024-Q2
Increased
1M
+1900.6%
$105.9M0.1%$100.45
48

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used